Skip to main content
. 2022 May 12;139(19):2931–2941. doi: 10.1182/blood.2021012743

Table 2.

Response by treatment arm

HU (n = 86), % PEG (n = 82), % Difference in proportions for combined ET/PV, 95% CI (PEG – HU) Rate ratio (95% CI)
12 mo
 Complete response 32 (37) 29 (35) −2% 0.95
  ET 19 (45) 17 (44) (−16 to 13) (0.64, 1.42)
  PV 13 (30) 12 (28)
 Overall response 60 (70) 64 (78) 8% 1.12
  ET 30 (71) 27 (69) (−5 to 21) (0.93, 1.34)
  PV 30 (68) 37 (86)
24 mo (n = 54)* (n = 52)*
 Complete response 11 (20) 15 (29) 9% 1.42
  ET 6 (25) 9 (38) (−9 to 26) (0.72, 2.79)
  PV 5 (17) 7 (25)
 Overall response 22 (41) 31 (60) 19% 1.46
  ET 8 (33) 14 (58) (1 to 37) (1.00, 2.16)
  PV 14 (47) 17 (61)
36 mo (n = 30) (n = 27)
 Complete response 5 (17) 9 (33) 17% 2.0
  ET 2 (17) 4 (40) (−8 to 40) (0.76, 5.23)
  PV 3 (17) 5 (29)
 Overall response 14 (47) 16 (59) 13% 1.27
  ET 4 (33) 6 (60) (−15 to 38) (0.77, 2.08)
  PV 10 (56) 10 (59)

Overall response rate = complete + partial response.

*

n = 106 patients (HU: 54, PEG: 52) who had the opportunity to receive treatment of 24 mo.

n = 57 patients (HU: 30, PEG: 27) who had the opportunity to receive treatment of 36 mo.